Glenmede Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

Glenmede Trust’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$77.7K	–	1338
2022 Q4	$77.7K	Hold	1,000	–	–	﹤0.01%	1166
2022 Q3	$67K	Hold	1,000	–	–	﹤0.01%	1163
2022 Q2	$76K	Hold	1,000	–	–	﹤0.01%	1170
2022 Q1	$79K	Hold	1,000	–	–	﹤0.01%	1209
2021 Q4	$76K	Hold	1,000	–	–	﹤0.01%	1216
2021 Q3	$72K	Hold	1,000	–	–	﹤0.01%	1192
2021 Q2	$73K	Hold	1,000	–	–	﹤0.01%	1187
2021 Q1	$69K	Hold	1,000	–	–	﹤0.01%	1116
2020 Q4	$66K	Hold	1,000	–	–	﹤0.01%	1118
2020 Q3	$62K	Hold	1,000	–	–	﹤0.01%	1287
2020 Q2	$62K	Hold	1,000	–	–	﹤0.01%	1266
2020 Q1	$64K	Hold	1,000	–	–	﹤0.01%	1584
2019 Q4	$64K	Hold	1,000	–	–	﹤0.01%	1584
2019 Q3	$56	Hold	1,000	–	–	﹤0.01%	1609
2019 Q2	$58	Hold	1,000	–	–	﹤0.01%	1608
2019 Q1	$60	Hold	1,000	–	–	﹤0.01%	1599
2018 Q4	$54	Buy	+1,000	New	+$60.6K	﹤0.01%	1554
2018 Q3	–	Sell	-1,000	Closed	-$59K	–	1738
2018 Q2	$59K	Hold	1,000	–	–	﹤0.01%	1392
2018 Q1	$59K	Hold	1,000	–	–	﹤0.01%	1567
2017 Q4	$59K	Hold	1,000	–	–	﹤0.01%	1567
2017 Q3	$57K	Hold	1,000	–	–	﹤0.01%	1601
2017 Q2	$55K	Hold	1,000	–	–	﹤0.01%	1560
2017 Q1	$55K	Hold	1,000	–	–	﹤0.01%	1560
2016 Q4	$52K	Hold	1,000	–	–	﹤0.01%	1596
2016 Q3	$57K	Hold	1,000	–	–	﹤0.01%	1571
2016 Q2	$58K	Hold	1,000	–	–	﹤0.01%	1526
2016 Q1	$57K	Hold	1,000	–	–	﹤0.01%	1481
2015 Q4	$65K	Hold	1,000	–	–	﹤0.01%	1483
2015 Q3	$62K	Hold	1,000	–	–	﹤0.01%	1519
2015 Q2	$70K	Hold	1,000	–	–	﹤0.01%	1519
2015 Q1	$70K	Sell	1,000 -204	-17%	-$13.8K	﹤0.01%	1573
2014 Q4	$77K	Hold	1,204	–	–	﹤0.01%	1618
2014 Q3	$75K	Hold	1,204	–	–	﹤0.01%	1576
2014 Q2	$74K	Buy	1,204 +204	+20%	+$12.1K	﹤0.01%	1516
2014 Q1	$58K	Hold	1,000	–	–	﹤0.01%	1606
2013 Q4	$53K	Hold	1,000	–	–	﹤0.01%	1607
2013 Q3	$47K	Hold	1,000	–	–	﹤0.01%	1612
2013 Q2	$45K	Buy	+1,000	New	+$46.2K	﹤0.01%	1547

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Glenmede Trust's PPH Position: Q1 2023 in Review

Glenmede Trust sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2023, closing a stake of 1,000 shares — an estimated $77.7K sold.

Glenmede Trust first reported a position in PPH in Q2 2013 and held it in 38 quarters. The position peaked at $79K in Q1 2022. 106 funds tracked by Wall St. Rank hold PPH as of Q1 2023.

Glenmede Trust reported no remaining VanEck Pharmaceutical ETF position as of Q1 2023 after selling out during the quarter.
Glenmede Trust sold 1,000 VanEck Pharmaceutical ETF shares in Q1 2023, an estimated $77.7K.
Glenmede Trust first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 38 quarters.
Glenmede Trust's VanEck Pharmaceutical ETF position peaked at $79K in Q1 2022.
106 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2023.

Based on Glenmede Trust's 13F filing for Q1 2023, filed 15 May 2023.